7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Fractures, Bone D050723 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hypercalciuria D053565 4 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteophyte D054850 2 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Pichler K et al. RANKL is downregulated in bone cells by physical activity (treadmill and vibration stimulation training) in rat with glucocorticoid-induced osteoporosis. 2013 Histol. Histopathol. pmid:23553492
Tantikanlayaporn D et al. A diarylheptanoid phytoestrogen from Curcuma comosa, 1,7-diphenyl-4,6-heptadien-3-ol, accelerates human osteoblast proliferation and differentiation. 2013 Phytomedicine pmid:23557993
Rahnama M et al. Influence of hormone replacement therapy on osteoprotegerin and receptor activator of nuclear factor kappa-B ligand concentrations in menopausal women. 2013 J. Interferon Cytokine Res. pmid:23745763
Rakic M et al. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. 2013 Clin Oral Implants Res pmid:22708989
Okamura H et al. Protein phosphatase 2A Cα is involved in osteoclastogenesis by regulating RANKL and OPG expression in osteoblasts. 2013 FEBS Lett. pmid:23183242
Silva HC et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. 2013 Bone pmid:23142805
Sivagurunathan S et al. Thrombin inhibits osteoclast differentiation through a non-proteolytic mechanism. 2013 J. Mol. Endocrinol. pmid:23419317
Fekete S et al. The effect of levetiracetam on rat bone mass, structure and metabolism. 2013 Epilepsy Res. pmid:24035343
Song JF et al. Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. 2013 Genet. Mol. Res. pmid:24065669
Lin C et al. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells. 2013 PLoS ONE pmid:23469146
Yu F et al. Association between osteoprotegerin genetic variants and osteoporosis in Chinese postmenopausal women. 2013 Endocr. J. pmid:24067544
Wu LZ et al. Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. 2013 Int. J. Mol. Med. pmid:23443505
Nishigaki M et al. β-cryptoxanthin regulates bone resorption related-cytokine production in human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:23452546
Jiang W et al. Identification of five serum protein markers for detection of ovarian cancer by antibody arrays. 2013 PLoS ONE pmid:24116163
Canalis E et al. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling. 2013 J. Biol. Chem. pmid:23884415
Szymczak J and Bohdanowicz-Pawlak A Osteoprotegerin, RANKL, and bone turnover in primary hyperparathyroidism: the effect of parathyroidectomy and treatment with alendronate. 2013 Horm. Metab. Res. pmid:23888411
Gordin D et al. Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes. 2013 Diabetes Care pmid:23801795
Fu YX et al. Inhibitory effects of osteoprotegerin on osteoclast formation and function under serum-free conditions. 2013 J. Vet. Sci. pmid:23820214
Eleftheriadis T et al. Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients. 2013 Int Urol Nephrol pmid:23296793
dos Santos PL et al. Guided implant surgery: what is the influence of this new technique on bone cell viability? 2013 J. Oral Maxillofac. Surg. pmid:23298799
Hoy J et al. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. 2013 J. Bone Miner. Res. pmid:23299909
Yassuda DH et al. Magnesium incorporation into β-TCP reduced its in vivo resorption by decreasing parathormone production. 2013 J Biomed Mater Res A pmid:23239606
Velusamy SK et al. Lactoferrin knockout mice demonstrates greater susceptibility to Aggregatibacter actinomycetemcomitans-induced periodontal disease. 2013 J. Periodontol. pmid:23327622
Gümüş P et al. Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease. 2013 J. Periodontol. pmid:23327689
Rosenheck S The heart and the osteoclasts. 2013 Cardiology pmid:23328209
Frederiksen L et al. Osteoprotegerin levels decrease during testosterone therapy in aging men and are associated with changed distribution of regional fat. 2013 Horm. Metab. Res. pmid:22918704
Bosselut N et al. Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy. 2013 Clin. Chim. Acta pmid:23022619
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Wang Y et al. Curculigoside isolated from Curculigo orchioides prevents hydrogen peroxide-induced dysfunction and oxidative damage in calvarial osteoblasts. 2012 Acta Biochim. Biophys. Sin. (Shanghai) pmid:22427460
Tobón-Arroyave SI et al. Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. 2012 J. Clin. Periodontol. pmid:23039038
Yang Y et al. [Association between osteoprotegerin gene polymorphisms and severe pre-eclampsia in Chinese women]. 2012 Zhonghua Fu Chan Ke Za Zhi pmid:22455689
Lekva T et al. TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover. 2012 Eur. J. Endocrinol. pmid:22450549
Ming LG et al. [Effect of osthol on apoptosis and bone resorption of osteoclasts cultured in vitro]. 2012 Yao Xue Xue Bao pmid:22512027
Wang N et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. 2012 Mol. Endocrinol. pmid:22108801
Boumans MJ et al. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. 2012 Ann. Rheum. Dis. pmid:22072013
Chen X et al. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. 2012 Biol Trace Elem Res pmid:22076734
Robinson DE et al. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. 2012 Biomaterials pmid:22079008
Aliprantis AO et al. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. 2012 FASEB J. pmid:22125315
Janda K et al. [The relationship between advancement of secondary hyperparathyroidism and selected calcification parameters in peritoneal dialysis patients]. 2012 Prz. Lek. pmid:23750431
Martínez-Calatrava MJ et al. RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis. 2012 Arthritis Res. Ther. pmid:22709525
Kim H et al. The association between polymorphisms in Wnt antagonist genes and bone response to hormone therapy in postmenopausal Korean women. 2012 Menopause pmid:22668815
Marzaioli V et al. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes. 2012 Arthritis Rheum. pmid:22674155
Tanaka M et al. Effect of Reveromycin A on experimental tooth movement in OPG-/- mice. 2012 J. Dent. Res. pmid:22674934
Yan J et al. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone. 2012 Am. J. Pathol. pmid:22640808
Kim S et al. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. 2012 Diagn. Microbiol. Infect. Dis. pmid:22647538
Jørgensen L et al. Osteoprotegerin is associated with hip fracture incidence: the Tromso Study. 2012 Int J Epidemiol pmid:22538253
Vasconcelos AC et al. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation. 2012 J. Oral Pathol. Med. pmid:22417074
Hwang JJ et al. Receptor activator of nuclear factor-κB ligand (RANKL) and its relationship to coronary atherosclerosis in HIV patients. 2012 J. Acquir. Immune Defic. Syndr. pmid:22842843
Liang W et al. Icariin promotes bone formation via the BMP-2/Smad4 signal transduction pathway in the hFOB 1.19 human osteoblastic cell line. 2012 Int. J. Mol. Med. pmid:22842877
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Fossmark R et al. Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. 2012 J. Cell. Biochem. pmid:21882222
Altan BA et al. Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. 2012 Lasers Med Sci pmid:21038101
Banfi G et al. Osteoprotegerin, RANK and RANKL are not modified by acute exercise in elite rugby players. 2012 J Sports Med Phys Fitness pmid:22525657
Wilkison M et al. Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. 2012 Am. J. Pathol. pmid:22626807
Wang QP et al. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. 2012 Bone pmid:22634178
Brunetti G et al. Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene. 2012 Endocrine pmid:22638612
Lacey DL et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. 2012 Nat Rev Drug Discov pmid:22543469
Campia U et al. Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque. 2012 Heart pmid:22543836
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Dougall WC Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. 2012 Clin. Cancer Res. pmid:22031096
Sakai N et al. Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. 2012 Hepatology pmid:22031462
Li YQ et al. Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone. 2012 Acta Pharmacol. Sin. pmid:22120966
Babür C et al. Gingival crevicular fluid levels of osteoprotegerin (OPG) in premenopausal and postmenopausal women with or without chronic periodontitis. 2012 J Dent pmid:22326720
Bataille C et al. Different sympathetic pathways control the metabolism of distinct bone envelopes. 2012 Bone pmid:22326888
Taylor RM et al. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst. 2012 Lab. Invest. pmid:22330339
Wei W et al. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22315431
Hulin-Curtis SL et al. Tumour necrosis factor receptor superfamily member 11B polymorphisms and association with knee osteoarthritis in women. 2012 Int. J. Immunogenet. pmid:22296645
Fitzgerald O and Chandran V Update on biomarkers in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. 2012 J. Rheumatol. pmid:22298273
Feng G et al. Single-nucleotide polymorphism of the osteoprotegerin gene and its association with bone mineral density in Chinese postmenopausal women. 2012 J. Pediatr. Endocrinol. Metab. pmid:23329761
Hogrefe C et al. Single impact cartilage trauma and TNF-α: interactive effects do not increase early cell death and indicate the need for bi-/multidirectional therapeutic approaches. 2012 Int. J. Mol. Med. pmid:22922824
Pereda GO et al. Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. 2012 Aust Dent J pmid:22924350
Tyagi AM et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. 2012 PLoS ONE pmid:22970248
Kadoglou NP et al. Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms. 2012 Regul. Pept. pmid:22982141
Feng Q et al. [Effect of sonicated extracts of Porphyromonas gingivalis on receptor activator of NF-κB ligand and osteoprotegerin expression in periodontal ligament cells]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:23302383
Yilmaz Y and Eren F Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. 2012 Clin. Chim. Acta pmid:22985537
Yan J et al. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling. 2012 J. Cell. Mol. Med. pmid:22947224
Kwon SR et al. Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy. 2012 Rheumatol. Int. pmid:21833531
Jia P et al. [The effect of ferric ion on the differentiation of osteoclast and bone resorption]. 2012 Zhonghua Yi Xue Za Zhi pmid:23158430
Jacot W et al. Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy. 2012 Breast Cancer Res. Treat. pmid:22562178
Dieset I et al. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein. 2012 Schizophr. Res. pmid:22817875
Wang F et al. Icariin enhances the healing of rapid palatal expansion induced root resorption in rats. 2012 Phytomedicine pmid:22818561
Chen B et al. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation. 2012 Phytomedicine pmid:22818895
Kaneko K et al. Changes of serum soluble receptor activator for nuclear factor-κB ligand after glucocorticoid therapy reflect regulation of its expression by osteoblasts. 2012 J. Clin. Endocrinol. Metab. pmid:22791764
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Crotti TN et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints. 2012 Arthritis Res. Ther. pmid:23146195
Yao Y et al. [The effect of bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis]. 2012 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:22934505
Jansson AM et al. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23023373
Taylan A et al. Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. 2012 BMC Musculoskelet Disord pmid:23025387
Dey P et al. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. 2012 Mol. Endocrinol. pmid:23028063
Song TJ et al. Association of plasma osteoprotegerin levels with stroke severity and functional outcome in acute ischaemic stroke patients. 2012 Biomarkers pmid:23030274
Galli C et al. Effect of surface treatment on cell responses to grades 4 and 5 titanium for orthodontic mini-implants. 2012 Am J Orthod Dentofacial Orthop pmid:22640672
Ostrowska Z et al.  Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. 2012 Postepy Hig Med Dosw (Online) pmid:23001207
Ramirez-Yanez GO and Symons AL Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: an in vitro study. 2012 Arch. Oral Biol. pmid:22480456
Dalbeth N and McQueen FM Clarification of the modified radiographic damage scoring method for gout. 2012 J. Rheumatol. pmid:22467953
Taddei SR et al. Experimental model of tooth movement in mice: a standardized protocol for studying bone remodeling under compression and tensile strains. 2012 J Biomech pmid:23036306

Table of Content